NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NASDAQ·Healthcare·Biotechnology
$28.33
-6.98%
Mkt Cap $3.42B
Next Earnings
In 8 daysThu, May 7, 2026
EPS Estimate
-$0.46
8 analysts
Revenue Estimate
$1.09M
Last quarter: missed by -57.50% on EPS, -97.44% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$3.42B
P/E
—
Fwd P/E
—
P/S
151.85
Rev TTM
—
EPS TTM
-$1.75